ConductScience.org, home

Paper39217384

The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension.

Lee HY and 12 others. Clin Hypertens, 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension. Papers, record 39217384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39217384

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension.
PubMed
Journal
Clin Hypertens
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.15, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee HYHae Young
2Ko SHSeung-Hyun
3Park SSungjoon
4Kim KKyuho
5Kim SYSong-Yi
6Cho IJIn-Jeong
7Cho EJEun Joo
8Kim HCHyeon Chang
9Park JHJae-Hyeong
10Ryu SKSung Kee
11Moon MKMin Kyong
12Ihm SHSang-Hyunhttps://orcid.org/0000-0001-5017-5421
13Korean Society of HypertensionGroup

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References132

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136788612The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension.Clin Hypertens2023https://conductscience.org/library/papers/36788612PubMed
237356031Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48.Diabetes Care2023https://conductscience.org/library/papers/37356031PubMed
327295427Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med2016https://conductscience.org/library/papers/27295427PubMed
426630143Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.N Engl J Med2015https://conductscience.org/library/papers/26630143PubMed
533470881Direct medical costs of obesity in the United States and the most populous states.J Manag Care Spec Pharm2021https://conductscience.org/library/papers/33470881PubMed
631924562The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial.Lancet Diabetes Endocrinol2020https://conductscience.org/library/papers/31924562PubMed
733292736Metabolomics profiling in hypertension and blood pressure regulation: a review.Clin Hypertens2020https://conductscience.org/library/papers/33292736PubMed
824796231Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J).Hepatol Res2015https://conductscience.org/library/papers/24796231PubMed
937356073Effects of treatment with Glucagon-like peptide-1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta-analysis.Diabetes Metab Res Rev2023https://conductscience.org/library/papers/37356073PubMed
1036977782Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action.Nat Rev Cardiol2023https://conductscience.org/library/papers/36977782PubMed
1116275870Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.Circulation2005https://conductscience.org/library/papers/16275870PubMed
1234450083Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.Lancet2021https://conductscience.org/library/papers/34450083PubMed
136877358Exon duplication and divergence in the human preproglucagon gene.Nature1983https://conductscience.org/library/papers/6877358PubMed
1437524445Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses.Gut2023https://conductscience.org/library/papers/37524445PubMed
1533685583Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.Elife2021https://conductscience.org/library/papers/33685583PubMed
1616936160Effect of weight loss with lifestyle intervention on risk of diabetes.Diabetes Care2006https://conductscience.org/library/papers/16936160PubMed
1733068776GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.Mol Metab2021https://conductscience.org/library/papers/33068776PubMed
1837122032Suboptimal control status of young hypertensive population.Clin Hypertens2023https://conductscience.org/library/papers/37122032PubMed
1935624390Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management.Curr Atheroscler Rep2022https://conductscience.org/library/papers/35624390PubMed
2026803771GLP-1 Agonists and Blood Pressure: A Review of the Evidence.Curr Hypertens Rep2016https://conductscience.org/library/papers/26803771PubMed

See all 132 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42783463Effects of Liraglutide and Semaglutide on Cardiometabolic Dysregulation and Oxidative Stress in an Experimental Model of Metabolic Syndrome.Med Sci (Basel)2026https://conductscience.org/library/papers/42783463PubMed
42583966Systemic pathways linking subcutaneous therapies to gastrointestinal adverse effects: A Narrative review of mechanisms and mitigation strategies.Indian J Pharmacol2026https://conductscience.org/library/papers/42583966PubMed
42429894Combination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies.Am J Cardiovasc Drugs2026https://conductscience.org/library/papers/42429894PubMed
42243292Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes.Hypertens Res2026https://conductscience.org/library/papers/42243292PubMed
42056284Consensus on the management of hypertension in individuals with diabetes by Asian-Pacific Society of hypertension (APSH) & Diabetes Asia Study Group (DASG).J Hum Hypertens2026https://conductscience.org/library/papers/42056284PubMed
41178712GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity.J Clin Invest2025https://conductscience.org/library/papers/41178712PubMed
40497273Impact of Perioperative Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes Following Carpal Tunnel Release.J Hand Surg Glob Online2025https://conductscience.org/library/papers/40497273PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39217384

GET https://conductscience.org/api/papers/v1/39217384/references?page=2